Yingjuan June Lu - Dec 31, 2024 Form 3 Insider Report for BeyondSpring Inc. (BYSI)

Role
Chief Scientific Officer
Signature
/s/ Yingjuan June Lu
Stock symbol
BYSI
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
3
Date filed
12/31/2024, 01:34 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BYSI Ordinary Shares 100 Dec 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BYSI Stock Options (right to buy) Dec 31, 2024 Ordinary Shares 10K $16.55 Direct F1
holding BYSI Stock Options (right to buy) Dec 31, 2024 Ordinary Shares 2K $4.26 Direct F2
holding BYSI Stock Options (right to buy) Dec 31, 2024 Ordinary Shares 5K $0.90 Direct F3
holding BYSI Stock Options (right to buy) Dec 31, 2024 Ordinary Shares 19.2K $1.33 Direct F4
holding BYSI Stock Options (right to buy) Dec 31, 2024 Ordinary Shares 50K $3.57 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 7,500 of the stock options are fully vested and exercisable. 2,500 of the stock options will vest on October 18, 2025.
F2 Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 2,003 stock options are fully vested and exercisable.
F3 Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 3,333 of the stock options are fully vested and exercisable. 1,667 of the stock options will vest on December 31, 2024.
F4 Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 6,393 of the stock options are fully vested and exercisable. 6,393 of the stock options will vest on December 31, 2024, and 6,394 of the stock options will vest on June 30, 2025.
F5 Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Inventive Plan. None of the stock options have become fully vested and exercisable. The stock options will vest in equal 25% installments on the first, second, third and fourth anniversaries of April 1, 2024.

Remarks:

As the Company no longer qualifies as a foreign private issuer, effective January 1, 2025, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company determined that it qualified as a foreign private issuer under the Exchange Act.